Insiders CRISPR Therapeutics AG

Stocks

CRSP

CH0334081137

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 07:52:12 21/07/2026 pm IST			5-day change	1st Jan Change
48.32 ^USD	+2.82%		-4.66%	-8.26%

30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark	CI
30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2500 Growth Benchmark	CI

Insiders

25/03	Crispr Therapeutics Insider Sold Shares Worth $468,736, According to a Recent SEC Filing	MT
24/12	Crispr Therapeutics Insider Sold Shares Worth $559,549, According to a Recent SEC Filing	MT
18/25/18	Crispr Therapeutics Ag Insider Bought Shares Worth $51,499,918, According to a Recent SEC Filing	MT
10/25/10	CRISPR Therapeutics AG Elects Briggs W. Morrison, as Member of the Compensation Committee, Effective June 5, 2025	CI
27/25/27	CRISPR Therapeutics COO to Step Down	MT
27/25/27	Julianne Bruno to Step Down from CRISPR Therapeutics AG as Chief Operating Officer, Effective as of April 11, 2025	CI
23/24/23	CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer	MT
23/24/23	CRISPR Therapeutics Announces Executive Changes	CI
18/24/18	Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing	MT
17/24/17	Crispr Therapeutics Ag Insider Sold Shares Worth $1,607,177, According to a Recent SEC Filing	MT
20/23/20	CRISPR Therapeutics AG Announces Resignation of Phuong Khanh Morrow as Chief Medical Officer, Effective January 26, 2024	CI
07/23/07	CRISPR Therapeutics Co-founder Rodger Novak to Step Down as President, Chairman, Effective Sept. 15	MT
07/23/07	CRISPR Therapeutics Announces Leadership Transition Effective September 15, 2023	CI
02/23/02	Insider Sell: Crispr Therapeutics	MT
28/23/28	Insider Sell: Crispr Therapeutics	MT
01/23/01	Insider Sell: Crispr Therapeutics	MT
29/23/29	CRISPR Therapeutics AG Announces Resignation of Brad Bolzon to Board of Directors	CI
14/23/14	CRISPR Therapeutics Names Raju Prasad as Chief Financial Officer	MT
02/23/02	Insider Sell: Crispr Therapeutics	MT
03/23/03	Insider Sell: Crispr Therapeutics	MT
19/22/19	CRISPR Therapeutics Appoints Alex Harding, M.D., M.B.A., as Head of Business Development, Effective January 5, 2023	CI
01/22/01	Insider Sell: Crispr Therapeutics Ag	MT
27/22/27	CRISPR Therapeutics Chief Operating Officer Lawrence Klein to Step Down	MT
27/22/27	CRISPR Therapeutics Announces Executive Changes	CI
01/22/01	Insider Sell: Crispr Therapeutics	MT